OnPoint Vision, Inc. – Trademark Portfolio

Entity Type: 03

OnPoint Vision, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ACCURASEE. The owner is based in Aliso Viejo, CA.

6A Liberty Street, Suite 100

Aliso Viejo, CA 92656

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OnPoint Vision, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does OnPoint Vision, Inc. have?

OnPoint Vision, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does OnPoint Vision, Inc. file in?

OnPoint Vision, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are OnPoint Vision, Inc.'s most well-known trademarks?

OnPoint Vision, Inc.'s registered trademark portfolio includes well-known marks such as ACCURASEE. These are among 2 currently registered trademarks in the portfolio.

What is OnPoint Vision, Inc.'s trademark registration success rate?

OnPoint Vision, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.